Market Overview:
The global clinical risk assessment solution market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in this market can be attributed to the increasing demand for cloud-based solutions, rising incidence of chronic diseases, and growing need for risk-based assessments. Based on type, the global clinical risk assessment solution market is segmented into private cloud type, public cloud type, and hybrid cloud type. The private cloud type segment is expected to account for the largest share of the global clinical risk assessment solution market in 2018. This segment is projected to grow at a CAGR of 11% from 2018 to 2030.
Product Definition:
Clinical risk assessment solution is a software that helps to identify, assess and manage clinical risks. It is important for hospitals and other healthcare organizations as it can help improve patient safety.
Private Cloud Type:
The global private cloud type is a software-as-a-service (SaaS) based on the infrastructure that can be used to store and share data across multiple computers or devices connected to the internet. It is also known as personal cloud or internal cloud. The SaaS technology enables users to store applications, data, and programs for use by multiple users from different departments in a company over the internet.
Public Cloud Type:
The public cloud type is also known as third-party or hosted services. It is a model of computing where the software and hardware are owned by an organization (hosting company) and can be accessed by multiple users from different locations. The data & applications are stored on the hosting companies’ servers which offer high storage capacity, application availability, increased bandwidth & faster processing speed at very low cost compared to traditional on-premise solutions.
Application Insights:
The hospital segment dominated the global clinical risk assessment solution market in 2017. This can be attributed to factors such as increasing prevalence of chronic diseases, high cost of healthcare and rising number of hospitals and clinics. Furthermore, an increase in the volume of electronic medical records has led to an increased need for data integration across various systems. The other application segment is expected to exhibit significant growth over the forecast period owing to a rise in demand from pharmaceutical companies for post-marketing studies and research activities.
Clinical trials are considered as one of the important aspects while developing any drug or device for human use. However, a major concern that arises during clinical trials is patient safety & confidentiality; which requires proper risk management & assessment before undertaking any study related tasks or procedures on patients¢â‚¬â„¢ behalf Clinical trialists perform various tasks such as protocol design, data collection/monitoring etc.
Regional Analysis:
North America is expected to dominate the global market over the forecast period. The growth can be attributed to various factors such as increasing government initiatives, technological advancements, and growing demand for healthcare IT solutions in this region. Moreover, high adoption of cloud-based technologies by several hospitals and clinics in North America has resulted in a higher revenue share of CRAS systems within this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising investments by governments and private players for developing healthcare infrastructure coupled with improving medical services at affordable costs. In addition, increasing number of patients seeking medical assistance due to hectic work schedules will drive demand further. Furthermore, rapid economic development along with rising disposable income levels are contributing toward market growth across Asia Pacific countries such as China and India thereby boosting product penetration rates within these nations during the forecast period from 2018 To 2030 (USD Edition).
Growth Factors:
- Increasing demand for risk-based clinical decision support to improve patient outcomes
- Rising incidence of chronic diseases and need for early diagnosis and treatment
- Proliferation of big data and analytics, providing opportunities for Clinical Risk Assessment Solution providers to develop innovative solutions
- Growing focus on value-based care models and reimbursement schemes that incentivize better care coordination and risk management
- Emergence of new technologies such as artificial intelligence (AI) and machine learning that can help identify risks earlier, more accurately, and at a lower cost
Scope Of The Report
Report Attributes
Report Details
Report Title
Clinical Risk Assessment Solution Market Research Report
By Type
Private Cloud Type, Public Cloud Type, Hybrid Cloud Type
By Application
Hospital, Clinic, Other
By Companies
3M, Optum Inc., Cerner Corporation, Conduent Inc., Nuance Communications, Health Catalyst, HBI Solutions, Johns Hopkins University, Lightbeam Health Solutions, Dynamic Healthcare Systems, 4S Information Systems, Evolent Health, Pera Health
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Clinical Risk Assessment Solution Market Report Segments:
The global Clinical Risk Assessment Solution market is segmented on the basis of:
Types
Private Cloud Type, Public Cloud Type, Hybrid Cloud Type
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 3M
- Optum Inc.
- Cerner Corporation
- Conduent Inc.
- Nuance Communications
- Health Catalyst
- HBI Solutions
- Johns Hopkins University
- Lightbeam Health Solutions
- Dynamic Healthcare Systems
- 4S Information Systems
- Evolent Health
- Pera Health
Highlights of The Clinical Risk Assessment Solution Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Private Cloud Type
- Public Cloud Type
- Hybrid Cloud Type
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Clinical Risk Assessment Solution Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Clinical Risk Assessment Solution is a software application that helps healthcare providers identify and manage patient risks.
Some of the major companies in the clinical risk assessment solution market are 3M, Optum Inc., Cerner Corporation, Conduent Inc., Nuance Communications, Health Catalyst, HBI Solutions, Johns Hopkins University, Lightbeam Health Solutions, Dynamic Healthcare Systems, 4S Information Systems, Evolent Health, Pera Health.
The clinical risk assessment solution market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Clinical Risk Assessment Solution Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Clinical Risk Assessment Solution Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Clinical Risk Assessment Solution Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Clinical Risk Assessment Solution Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Clinical Risk Assessment Solution Market Size & Forecast, 2018-2028 4.5.1 Clinical Risk Assessment Solution Market Size and Y-o-Y Growth 4.5.2 Clinical Risk Assessment Solution Market Absolute $ Opportunity
Chapter 5 Global Clinical Risk Assessment Solution Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Clinical Risk Assessment Solution Market Size Forecast by Type
5.2.1 Private Cloud Type
5.2.2 Public Cloud Type
5.2.3 Hybrid Cloud Type
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Clinical Risk Assessment Solution Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Clinical Risk Assessment Solution Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Clinical Risk Assessment Solution Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Clinical Risk Assessment Solution Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Clinical Risk Assessment Solution Analysis and Forecast
9.1 Introduction
9.2 North America Clinical Risk Assessment Solution Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Clinical Risk Assessment Solution Market Size Forecast by Type
9.6.1 Private Cloud Type
9.6.2 Public Cloud Type
9.6.3 Hybrid Cloud Type
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Clinical Risk Assessment Solution Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Clinical Risk Assessment Solution Analysis and Forecast
10.1 Introduction
10.2 Europe Clinical Risk Assessment Solution Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Clinical Risk Assessment Solution Market Size Forecast by Type
10.6.1 Private Cloud Type
10.6.2 Public Cloud Type
10.6.3 Hybrid Cloud Type
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Clinical Risk Assessment Solution Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Clinical Risk Assessment Solution Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Clinical Risk Assessment Solution Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Clinical Risk Assessment Solution Market Size Forecast by Type
11.6.1 Private Cloud Type
11.6.2 Public Cloud Type
11.6.3 Hybrid Cloud Type
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Clinical Risk Assessment Solution Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Clinical Risk Assessment Solution Analysis and Forecast
12.1 Introduction
12.2 Latin America Clinical Risk Assessment Solution Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Clinical Risk Assessment Solution Market Size Forecast by Type
12.6.1 Private Cloud Type
12.6.2 Public Cloud Type
12.6.3 Hybrid Cloud Type
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Clinical Risk Assessment Solution Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Clinical Risk Assessment Solution Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Clinical Risk Assessment Solution Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Clinical Risk Assessment Solution Market Size Forecast by Type
13.6.1 Private Cloud Type
13.6.2 Public Cloud Type
13.6.3 Hybrid Cloud Type
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Clinical Risk Assessment Solution Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Clinical Risk Assessment Solution Market: Competitive Dashboard
14.2 Global Clinical Risk Assessment Solution Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 3M
14.3.2 Optum Inc.
14.3.3 Cerner Corporation
14.3.4 Conduent Inc.
14.3.5 Nuance Communications
14.3.6 Health Catalyst
14.3.7 HBI Solutions
14.3.8 Johns Hopkins University
14.3.9 Lightbeam Health Solutions
14.3.10 Dynamic Healthcare Systems
14.3.11 4S Information Systems
14.3.12 Evolent Health
14.3.13 Pera Health